On Oct. 2 at 10 a.m. Pacific (1 p.m. Eastern), Scientific Learning Corp. will present a free, online seminar by Norman Doidge, M.D., author of the New York Times and international bestseller, “The Brain That Changes Itself.”
Biological mechanisms in the brains of traders lead them to predict how others will behave, resulting in stock marketing bubbles crashing; a new study suggests.
Researchers reveal how two classes of drug compounds, which are currently in trial, work to fight Alzheimer’s disease. They also identify possible causes of early onset hereditary forms of AD.
Researchers have carried out the largest general neural network simulation to date using the computational power of the K computer.
Rensselaer becomes the first university of receive a version of IBM’s Watson system. Rensselaer hopes to find new uses for Watson and develop its cognitive capabilities, as well as using the system for Big Data research.
Researchers announced that the UK’s first operation to tackle heart failure with a novel nerve-stimulating device will be performed today. The implantable device operates by stimulating the vagus nerve on the right side of the neck.
Penn Medicine research presented today at the 2012 Alzheimer’s Association International Conference shows that an anti-tau treatment called epithilone D (EpoD) was effective in preventing and intervening the progress of Alzheimer’s disease in animal models, improving neuron function and cognition, as well as decreasing tau pathology.